Soberana Plus

Soberana Plus is a COVID-19 vaccine developed by the Finlay Institute in Cuba. It is a protein subunit vaccine that uses a part of the SARS-CoV-2 virus to stimulate an immune response.

Development

The development of Soberana Plus began in 2020, in response to the global COVID-19 pandemic. The vaccine was created by the Finlay Institute, a Cuban research organization that specializes in the production of vaccines and serums.

Efficacy

In clinical trials, Soberana Plus has shown a high level of efficacy against COVID-19. The vaccine has been found to be particularly effective when used as a booster shot following administration of other vaccines.

Distribution

As of 2021, Soberana Plus has been approved for use in Cuba and is being distributed to other countries around the world. The vaccine is part of Cuba's strategy to achieve herd immunity against COVID-19.

See also

• COVID-19 vaccination
• COVID-19 pandemic in Cuba
• Vaccination in Cuba

Soberana Plus Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski